VIB
FoundationGhent · Seed–Late Stage · 5 people tracked
Investment thesis
VIB is a Flemish life sciences research institute focused on conducting groundbreaking biomolecular research for scientific and societal benefit. It allocates most of its budget to research, with a significant share dedicated to technology transfer aimed at converting research into viable business ventures for consumer and patient benefit. Its research spans humans, plants, and microorganisms, studying normal and pathological cellular and organismal processes. Researchers are embedded within departments across four Flemish universities to foster collaboration. As a member of EU-LIFE, VIB emphasizes excellence in life sciences, dissemination of scientific knowledge to the public, and contribution to economic development.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & curated
What they invest in
from 5 of 5 portfolio companiesBiotech ×4Healthtech ×3AgTech ×1AI & Machine Learning ×1Enterprise Software ×1FoodTech ×1Medical Devices ×1SaaS ×1
HQs:Belgium×4
Investments · 5 tracked
founders shown can be your intro path
Montis Biosciences develops anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome and a second CD93 program in lung squamous cell carcinoma.
BiotechHealthtechLeuven, BE
Federico Grossi(Clinical Advisor & Acting CMO)
Co-investorsDroia VenturesPfizer VenturesPfizer Venture Investments
MRM Health is a clinical-stage biotech developing microbiome-based Live Biotherapeutic Products for chronic inflammatory diseases with high unmet needs, using its CORAL technology to design and manufacture disease-focused microbial consortia.
BiotechHealthtechMedical DevicesGhent, BE
Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.
AgTechBiotechFoodTechGent, BE
Benjamin Laga(Co-founder & CEO)Jonas Aper(Co-founder & Director of Breeding)
Co-investorsAgri Investment FundInnovation IndustriesKorysV-Bio VenturesEstari GroupPMV
Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.
BiotechHealthtechLeuven, BE
Federico Grossi(Clinical Advisor & Acting CMO)
Co-investorsDroia VenturesPfizer VenturesPfizer Venture Investments
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionFountain Healthcare PartnersHTGF+2 more
Frequently asked questions
- What stage does VIB invest at?
- VIB invests at the Seed, Series A, Late Stage stages.
- What sectors does VIB focus on?
- VIB focuses on AgTech, Biotech, FoodTech.
- Where is VIB located?
- VIB is headquartered in Ghent, BE.
- Does VIB lead rounds?
- VIB typically participates in rounds rather than leading them.
Media · Podcasts & interviews
from their channelNEW | Episode 14: Lia Martina – From pipettes to policy
VIB
NEW | Episode 12: Ayşe Candayan – Grants, genes, and grit
VIB
NEW | Episode 13: Thomas Jacobs – Transplanting, adapting, and flourishing in a new environment
VIB
NEW | Episode 11: Laurent Galibert – A lifelong mission in drug discovery
VIB
NEW | Episode 15: Inge Van Molle – What it takes to be a jack of all trades
VIB
BioImaging Core Cribs
VIB
Images
Similar investors
Redalpine is a multi-stage venture investment advisor with Swiss roots and a pan-European focus, active since 2006, that invests at the intersection of software and science.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Blue Horizon Corporation is an investment firm focused on accelerating the transition to a sustainable food system, aiming to deliver strong returns for people and the planet.
iSelect Fund is a venture investor focused on the convergence of agriculture technology and human health, backing companies that improve nutrition, food affordability and sustainability as well as data and delivery technologies for detecting and treating cardio-metabolic disease.
Clay Capital is a venture capital firm investing in high-impact agrifood technology, backing teams working to strengthen the link between human health and planetary health through innovation.